PubMed

Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans.

Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, Henry RR.

Am J Physiol Endocrinol Metab. 2009 Sep;297(3):E767-73. Epub 2009 Jul 21.PMID: 19622782 [PubMed - indexed for MEDLINE]Related articles

A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US *

Charles MS, Minshall ME, Pandya BJ, Baran RW, Tunis SL.

Curr Med Res Opin. 2009 May 6. [Epub ahead of print]PMID: 19419339 [PubMed - as supplied by publisher]Related articles

[Avandia and avandamet in the treatment of patients with diabetes mellitus type 2: effects on secretion of some fat tissue hormones]

Balabolkin MI, Mamaeva GG, Klebanova EM, Kuzin AG, Tel'nova ME, Kreminskaia VM.

Ter Arkh. 2008;80(10):21-6. Russian. PMID: 19105408 [PubMed - indexed for MEDLINE]Related articles

Comparison of fixed-dose rosiglitazone/metformin combination therapy with sulphonylurea plus metformin in overweight individuals with Type 2 diabetes inadequately controlled on metformin alone.

Hamann A, Garcia-Puig J, Paul G, Donaldson J, Stewart M.

Exp Clin Endocrinol Diabetes. 2008 Jan;116(1):6-13. Epub 2007 Dec 20.PMID: 18095238 [PubMed - indexed for MEDLINE]Related articles

Response to Pokharna and Kanna: initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.

Garber A.

Diabetes Obes Metab. 2008 May;10(5):436-7. Epub 2007 Jun 26. No abstract available. PMID: 17596200 [PubMed - indexed for MEDLINE]Related articles

Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.

Smiley D, Umpierrez G.

Expert Opin Pharmacother. 2007 Jun;8(9):1353-64. Review.PMID: 17563269 [PubMed - indexed for MEDLINE]Related articles

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.

Home PD, Bailey CJ, Donaldson J, Chen H, Stewart MW.

Diabet Med. 2007 Jun;24(6):618-25. Epub 2007 Apr 2.PMID: 17403121 [PubMed - indexed for MEDLINE]Related articlesFree article

Letter to the editor in reference to article titled: Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.

Pokharna H, Kanna B.

Diabetes Obes Metab. 2007 Nov;9(6):914. Epub 2007 Mar 29. No abstract available. PMID: 17394564 [PubMed - indexed for MEDLINE]Related articles

Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.

Rosenstock J, Rood J, Cobitz A, Biswas N, Chou H, Garber A.

Diabetes Obes Metab. 2006 Nov;8(6):650-60.PMID: 17026489 [PubMed - indexed for MEDLINE]Related articles

Improvement in glycaemic control with rosiglitazone/metformin fixed-dose combination therapy in patients with type 2 diabetes with very poor glycaemic control.

Rosenstock J, Rood J, Cobitz A, Huang C, Garber A.

Diabetes Obes Metab. 2006 Nov;8(6):643-9.PMID: 17026488 [PubMed - indexed for MEDLINE]Related articles

[Recent oral antidiabetic therapy]

Herbaut C.

Rev Med Brux. 2005 Sep;26(4):S235-40. Review. French. PMID: 16240868 [PubMed - indexed for MEDLINE]Related articles

Manufacturing violations prompt seizure of Paxil CR, Avandamet.

[No authors listed]

FDA Consum. 2005 May-Jun;39(3):4-5. No abstract available. PMID: 16130202 [PubMed - indexed for MEDLINE]Related articlesFree article

Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.

Derosa G, Gaddi AV, Piccinni MN, Ciccarelli L, Salvadeo S, Peros E, Ghelfi M, Ferrari I, Cicero AF.

Pharmacotherapy. 2005 May;25(5):637-45.PMID: 15899724 [PubMed - indexed for MEDLINE]Related articles

Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.

Bailey CJ, Day C.

Int J Clin Pract. 2004 Sep;58(9):867-76. Review.PMID: 15529521 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone plus metformin: combination therapy for Type 2 diabetes.

Del Prato S, Volpe L.

Expert Opin Pharmacother. 2004 Jun;5(6):1411-22. Review. Erratum in: Expert Opin Pharmacother. 2004 Sep;5(9):2051. PMID: 15163284 [PubMed - indexed for MEDLINE]Related articles

[Blood sugar inspite of maximal metformin dosage. New fixed combination forces HbA1c down]

[No authors listed]

MMW Fortschr Med. 2003 Dec 11;145(50):54. German. No abstract available. PMID: 14963975 [PubMed - indexed for MEDLINE]Related articles

New drugs and dosage forms.

[No authors listed]

Am J Health Syst Pharm. 2003 Oct 1;60(19):1942. No abstract available. PMID: 14531237 [PubMed - indexed for MEDLINE]Related articles

Diabetes medicine update. Old dogs, new tricks.

Nakamoto M.

Diabetes Self Manag. 2003 Jan-Feb;20(1):14-5. No abstract available. PMID: 12632553 [PubMed - indexed for MEDLINE]Related articles

Dutasteride (Avodart) for benign prostatic hyperplasia.

[No authors listed]

Med Lett Drugs Ther. 2002 Dec 23;44(1146):109-10. No abstract available. PMID: 12500154 [PubMed - indexed for MEDLINE]Related articles

Metaglip and Avandamet for type 2 diabetes.

[No authors listed]

Med Lett Drugs Ther. 2002 Dec 23;44(1146):107-9. No abstract available. PMID: 12500153 [PubMed - indexed for MEDLINE]Related articles